These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14582458)

  • 21. Spreading your way to lower cholesterol?
    Harv Heart Lett; 2002 Feb; 12(6):1-3. PubMed ID: 11869965
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of phytosterols in diacylglycerol as part of diet therapy on hyperlipidemia in children.
    Matsuyama T; Shoji K; Takase H; Kamimaki I; Tanaka Y; Otsuka A; Watanabe H; Hase T; Tokimitsu I
    Asia Pac J Clin Nutr; 2007; 16(1):40-8. PubMed ID: 17215179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs.
    Goldberg AC; Ostlund RE; Bateman JH; Schimmoeller L; McPherson TB; Spilburg CA
    Am J Cardiol; 2006 Feb; 97(3):376-9. PubMed ID: 16442399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological evaluation of chalcones and analogues as hypolipidemic agents.
    Santos L; Curi Pedrosa R; Correa R; Cechinel Filho V; Nunes RJ; Yunes RA
    Arch Pharm (Weinheim); 2006 Oct; 339(10):541-6. PubMed ID: 17009298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia.
    Burnett JR
    Curr Opin Investig Drugs; 2006 Sep; 7(9):850-6. PubMed ID: 17002264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
    Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
    Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia.
    Burnett JR
    Curr Opin Mol Ther; 2006 Oct; 8(5):461-7. PubMed ID: 17078389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-fat formulations of plant stanols and sterols.
    Salo P; Wester I
    Am J Cardiol; 2005 Jul; 96(1A):51D-54D. PubMed ID: 15992517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytosterols in nonfat and low-fat beverages have no impact on the LDL size phenotype.
    Charest A; Vanstone C; St-Onge MP; Parson W; Jones PJ; Lamarche B
    Eur J Clin Nutr; 2005 Jun; 59(6):801-4. PubMed ID: 15856068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrates in the treatment of hyperlipidemia].
    Kłosiewicz-Latoszek L; Szostak WB
    Wiad Lek; 1993 Nov; 46(21-22):872-6. PubMed ID: 7817584
    [No Abstract]   [Full Text] [Related]  

  • 34. NCX-4016 NicOx.
    Di Napoli M; Papa F
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1126-39. PubMed ID: 14582459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eflucimibe. Pierre Fabre/Eli Lilly.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Mar; 4(3):347-51. PubMed ID: 12735237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of phytosterols as cholesterol lowering agents.
    Haidar ; Soeatmadji DW
    Acta Med Indones; 2004; 36(3):163-8. PubMed ID: 15557687
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of dyslipoproteinemia risk factor. Lipid therapy must become multidimensional].
    MMW Fortschr Med; 2008 Jun; 150(26-27):52-3. PubMed ID: 18681233
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of plant sterols on hypercholesterolemia].
    Reiner Z; Tedeschi-Reiner E
    Lijec Vjesn; 2007; 129(8-9):276-81. PubMed ID: 18198627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.